Insider · CIK 0001323304
Mary Tagliaferri
Files at ENZ (ENZO BIOCHEM INC), YMAB (Y-mAbs Therapeutics, Inc.), RYZB (RayzeBio, Inc.). First filing -, latest -.
In brief
Mary Tagliaferri files SEC Form 4 as director at ENZ (ENZO BIOCHEM INC), and also at YMAB (Y-mAbs Therapeutics, Inc.), RYZB (RayzeBio, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Mary Tagliaferri has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 7 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 11, 2024 | YMAB Y-mAbs Therapeutics, Inc. | AGrant or award Common Stock | +3,495 | $0.00 | $0 | 8,155 | Jun 13, 2024 |
| Jun 11, 2024 | YMAB Y-mAbs Therapeutics, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +14,545 | $0.00 | $0 | 14,545 | Jun 13, 2024 |
| Mar 12, 2024 | YMAB Y-mAbs Therapeutics, Inc. | AGrant or award Common Stock | +4,660 | $0.00 | $0 | 4,660 | Mar 14, 2024 |
| Mar 12, 2024 | YMAB Y-mAbs Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +27,900 | $0.00 | $0 | 27,900 | Mar 14, 2024 |
| Feb 26, 2024 | RYZB RayzeBio, Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -73,731 | - | - | 0 | Feb 27, 2024 |
| Feb 26, 2024 | RYZB RayzeBio, Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -40,848 | - | - | 0 | Feb 27, 2024 |
| Jan 31, 2024 | ENZ ENZO BIOCHEM INC | AGrant or award Common Stock | +79,365 | $0.00 | $0 | 312,383 | Feb 2, 2024 |
Questions about Mary Tagliaferri
Answered from the filings on this page, as of the latest one.
Is Mary Tagliaferri buying or selling?
Mary Tagliaferri has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Mary Tagliaferri's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Mary Tagliaferri has 0.
Where does Mary Tagliaferri file Form 4?
Mary Tagliaferri has filed Form 4 at ENZ (ENZO BIOCHEM INC); YMAB (Y-mAbs Therapeutics, Inc.); RYZB (RayzeBio, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.